Clinical trials for Colon cancer

169 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 3 Colon cancer Rectal cancer #NCT05078047

[MOIO] Étude comparant l'administration standard d'une immunothérapie (IO) vs la même IO administrée tous les 3 mois chez des patients en réponse après 6 mois d'IO standard

Adenocarcinoma Locally Advanced Metastatic MSI/dMMR Immunotherapy

26 recruiting sites

UNICANCER

Phase 3 Colon cancer Rectal cancer # NCT06642844

[PHARBEVACOL] Chimiothérapie à base de BEVACIZUMAB adaptée à la pharmacocinétique du bévacizumab en traitement de première intention

Adenocarcinoma Metastatic None Systemic Treatment-Naive

2 recruiting sites

Centre Hospitalier Universitaire de Tours

Phase 2 / Phase 3 Colon cancer Rectal cancer #NCT05462613 #2024-516709-22-00

[REPROGRAM-02] Étude du RÉGORAFÉNIB avec chimiothérapie à faible dose et aspirine, suivi de chimiothérapie standard dans le cancer colorectal métastatique

Metastatic 1 Surgery Chemotherapy Targeted therapy

Systemic Treatment-Naive

11 recruiting sites

CHU de Besançon

Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer Small intestine and appendix cancer Thyroid and adrenal gland cancer #NCT03175224 #2024-514542-37-00

[SPARTA] APL-101 chez des patients atteints de tumeurs solides avancées avec anomalies de MET - Cohortes C, D et F

Locally Advanced Metastatic MET 1 2 3 or more

BRAF EGFR KRAS G12C KRAS non G12C NTRK-1/2/3 RET ALK ROS-1 Systemic Treatment-Naive Targeted therapy

5 recruiting sites

Apollomics

Phase 2 Prostate cancer Colon cancer Rectal cancer Anal cancer Pancreas cancer Stomach and esophageal cancer Cervical / Vulvar / Vaginal cancer Small intestine and appendix cancer #NCT06333314 #2023-505298-34-00

[Pan-MSI-ACSE] DOSTARLIMAB pour le cancer localement avancé ou métastatique (non colorectal/non endométrial) avec tumeur dMMR/MSI